WANG Zhong-ying, LIU Hui-xia, LIU Li-qing, et al. Effects of Traditional Chinese Medicine on Expression of CD4T lymphocytes, Serum IL-12 and TNF- in Patients with Hashimoto's Thyroiditis[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(7): 191-194.
WANG Zhong-ying, LIU Hui-xia, LIU Li-qing, et al. Effects of Traditional Chinese Medicine on Expression of CD4T lymphocytes, Serum IL-12 and TNF- in Patients with Hashimoto's Thyroiditis[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(7): 191-194. DOI: 10.13422/j.cnki.syfjx.2016070191.
Objective: To investigate the potential action mechanism and observe the effects of traditional Chinese medicine compound (TCMC) on the expressions of anti-thyroid autoantibodies of Hashimoto's thyroiditis
serum interleukin-12 (IL-12) and tumor necrosis factor-α (TNF-α)
as well as the pathological changes of thyroid. Method: Seventy patients with Hashimoto's thyroiditis were randomly divided into two groups on average (no significant difference in sex
age and disease course):treatment group and non-treatment group. The patients in treatment group were treated with TCMC (one dose/day and 12 weeks/course)
while the patients in non-treatment group were treated with Euthyrox by oral administration. Before and after treatment
free triiodothyronine (FT3)
free (unbound) thyroxin (e) (FT4) and thyroid stimulating hormone (TSH) were tested once respectively. CD4+ TC
thyroid globulin antibody (TGAb)
thyroid peroxidase antibody (TPOAb)
IL-12 and TNF-α as thyroid immunological markers were also tested once respectively before and after treatment;coarse needle biopsy (CNB) was also done once respectively before and after treatment. Result: There was no statistically significant difference in thyroid function between two groups of patients before and after treatment
and there was no significant change in FT3
TSH
and FT4 in treatment group before and after treatment
indicating that Chinese medicine had no significant effect on thyroid hormone levels. Before treatment
there was no statistical difference in TGAb
TPOAb
IL-12
and TNF-α between two groups. CD4+ TC
TGAb
TPOAb
IL-12
TNF-α levels after treatment in treatment group were significantly lower than those before treatment and those in non-treatment group
indicating that this drug can well regulate immunity
reduce thyroid humoral immune damage
and promote tissue repair. Conclusion: This TCMC could mediate body immunity well
relieve the thyroid humoral immunity injury and accelerate the tissue repair
demonstrating protective and repairable function for the thyroid tissues of Hashimoto's thyroiditis.